You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Jardiance

Showing 26 - 50 of 118
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

End Stage Renal Disease Trial in Boston, New York (Empagliflozin 10 MG, Placebo)

Not yet recruiting
  • End Stage Renal Disease
  • Empagliflozin 10 MG
  • Placebo
  • Boston, Massachusetts
  • +1 more
Mar 15, 2023

Kidney Transplant, Type 2 Diabetes Trial in United States (Empagliflozin)

Not yet recruiting
  • Kidney Transplant
  • Type 2 Diabetes
  • Iowa City, Iowa
  • +3 more
Aug 22, 2023

Diabetes Type 2, NAFLD Trial in Minya (Empagliflozin 25 MG, Ursodeoxycholic acid, Pentoxifylline 400 MG)

Completed
  • Diabetes Type 2
  • NAFLD
  • Empagliflozin 25 MG
  • +3 more
  • Minya, Egypt
    Minya University Hospital
Jul 20, 2022

Pharmacogenomic, Pharmacokinetics Trial in Cairo (Empagliflozin 10 milligram)

Not yet recruiting
  • Pharmacogenomic
  • Pharmacokinetics
  • Empagliflozin 10 milligram
  • Cairo, Egypt
    Faculty of Pharmacy
Feb 5, 2022

Type2 Diabetes, Heart Failure With Preserved Ejection Fraction Trial in San Antonio (Empagliflozin 25 MG, Placebo)

Recruiting
  • Type2 Diabetes
  • Heart Failure With Preserved Ejection Fraction
  • Empagliflozin 25 MG
  • Placebo
  • San Antonio, Texas
  • +1 more
Jan 21, 2023

Type 2 Diabetes, Cardiovascular Risk Factor Trial in Catanzaro (Empagliflozin 10 MG, Glimepiride 2 mg)

Completed
  • Type 2 Diabetes
  • Cardiovascular Risk Factor
  • Empagliflozin 10 MG
  • Glimepiride 2 mg
  • Catanzaro, Italy
    Universital Hospital Mater Domini
Jan 14, 2023

Acute Heart Failure, Chronic Kidney Diseases Trial in Montreal (Empagliflozin 25 MG)

Not yet recruiting
  • Acute Heart Failure
  • Chronic Kidney Diseases
  • Empagliflozin 25 MG
  • Montreal, Quebec, Canada
    Research Institute of the McGill University Health Center
Mar 29, 2022

Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

Not yet recruiting
  • Diabetic Nephropathy Type 2
  • Empagliflozin 25 MG
  • Enalapril Maleate 20 mg
  • (no location specified)
May 9, 2022

Postprandial Hypoglycemia Trial in Basel, Bern, Olten (Empagliflozin (Jardiance®;, Placebo Control Intervention)

Recruiting
  • Postprandial Hypoglycemia
  • Empagliflozin (Jardiance®;
  • Placebo Control Intervention
  • Basel, Switzerland
  • +2 more
Mar 14, 2022

ivness and Safety in Elderly Type 2 Diabetes Patients

Not yet recruiting
  • Type2Diabetes
  • SGLT2 inhibitor
  • Milan, Italy
    ASST FBF Sacco
Jul 25, 2022

Cardiotoxicity Trial in Warsaw (Empagliflozin 10 MG, Placebo)

Not yet recruiting
  • Cardiotoxicity
  • Empagliflozin 10 MG
  • Placebo
  • Warsaw, Poland
  • +1 more
Mar 5, 2022

Congenital Heart Disease, Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in Mexico City (Sacubitril 49 MG /

Not yet recruiting
  • Congenital Heart Disease
  • +2 more
  • Sacubitril 49 MG / Valsartan 51 MG [Entresto] BID
  • Empagliflozin 10 MG OD
  • Mexico City, Mexico
    National Institute of Cardiology Ignacio Chavez
Oct 31, 2022

Non-Alcoholic Fatty Liver Disease, NAFLD, Pediatric NAFLD Trial in Minneapolis (Empagliflozin 10 MG, Placebo Oral Tablet)

Active, not recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
  • Empagliflozin 10 MG
  • Placebo Oral Tablet
  • Minneapolis, Minnesota
    University of Minnesota
Mar 2, 2022

Type2 Diabetes Trial in Herlev (Empagliflozin, Placebo Oral Tablet)

Completed
  • Type2 Diabetes Mellitus
  • Herlev, Denmark
    Herlev og Gentofte Hospital
Aug 17, 2022

Heart Failure Trial in Oxford (Empagliflozin, Placebo)

Completed
Has Results
  • Heart Failure
  • Oxford, United Kingdom
    John Radcliffe Hospital
May 26, 2021

Type2 Diabetes Trial in Tuebingen, Duesseldorf (Empagliflozin (Jardiance®), Insulin Glargine (Lantus®))

Active, not recruiting
  • Type2 Diabetes Mellitus
  • Empagliflozin (Jardiance®)
  • Insulin Glargine (Lantus®)
  • Tuebingen, Baden-Württemberg, Germany
  • +1 more
Dec 2, 2021

Acute Decompensated Heart Failure Trial in Grodzisk Mazowiecki (Empagliflozin 10 MG, Dapagliflozin 10 MG, Placebo)

Recruiting
  • Acute Decompensated Heart Failure
  • Empagliflozin 10 MG
  • +2 more
  • Grodzisk Mazowiecki, Poland
    Autonomous Public Specialist Western John Paul II Hospital
Mar 7, 2023

type1diabetes Trial in Columbus (Empagliflozin)

Not yet recruiting
  • type1diabetes
  • Columbus, Ohio
    Ohio State University
Jun 7, 2021

Diabetes Type 2 Without Complication Trial in Guadalajara (Dapagliflozin 10Mg Tab, Empagliflozin 25 MG, Placebo)

Active, not recruiting
  • Diabetes Mellitus Type 2 Without Complication
  • Dapagliflozin 10Mg Tab
  • +2 more
  • Guadalajara, Jalisco, Mexico
    Institute of Experimental and Clinical Therapeutics (INTEC), CUC
Nov 11, 2021

Metabolic Syndrome, Type 2 Diabetes, Obesity Trial in Perth (Empagliflozin Oral Tablet [Jardiance], Placebo Oral Tablet)

Recruiting
  • Metabolic Syndrome
  • +2 more
  • Empagliflozin Oral Tablet [Jardiance]
  • Placebo Oral Tablet
  • Perth, Western Australia, Australia
    Royal Perth Hospital
Sep 23, 2021

Obesity, Non-diabetic Chronic Kidney Disease Trial (Empagliflozin 10 MG)

Withdrawn
  • Obesity
  • Non-diabetic Chronic Kidney Disease
  • Empagliflozin 10 MG
  • (no location specified)
Sep 6, 2021

Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

Not yet recruiting
  • Diabetes Mellitus Type 2 With Proteinuria
  • +12 more
  • Empagliflozin 10 MG
  • +6 more
  • (no location specified)
Oct 17, 2023

Diabetes, Type 2, Diabetic Kidney Disease Trial in Amsterdam (Empagliflozin 10 MG, Losartan 50Mg Tab, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Diabetic Kidney Disease
  • Empagliflozin 10 MG
  • +2 more
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Oct 5, 2021

Glucose 6 Phosphatase Deficiency Trial in Warsaw (Empagliflozin)

Not yet recruiting
  • Glucose 6 Phosphatase Deficiency
  • Warsaw, Poland
    The Children's Memorial Health Institute
Jun 18, 2021

Chronic Kidney Disease stage3 Trial in Lódz (Empagliflozin 10 MG)

Recruiting
  • Chronic Kidney Disease stage3
  • Empagliflozin 10 MG
  • Łódź, Poland
    Department of Nephrology, Hypertension and Kidney Transplantatio
Jul 12, 2021